Product Information

LORAZEPAM 2 MG/ML ORAL CONCENT is a generic product labeled by Pharmaceutical Associates, Inc., priced at $0.6928 per ML under NDC 00121077001. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 15, 2010. Its Orange Book therapeutic-equivalence code is AA.

LORAZEPAM 2 MG/ML ORAL CONCENT

Lorazepam
$0.6928per ML
DEA Schedule CIV

Strength

2 mg/mL

NDC

00121077001

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LORAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA090260

FDA Approved

6/15/2010

TE Code

AA

On Market Since

11/1/2010

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 2.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6928 per ML
All-time high$0.8544 (Mar 12, 2014)
All-time low$0.5070 (May 23, 2018)
52-week high$0.6928
52-week low$0.6128
Median price$0.6251
Average price$0.6285
Largest weekly change+21.5% (May 17, 2023)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+4.1%

1M

+4.1%

3M

+9.6%

6M

+9.4%

1Y

+13.1%

3Y

+18.2%

5Y

+7.2%

All

+2.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lorazepam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LORAZEPAM 2 MG/ML ORAL CONCENT?

The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG/ML ORAL CONCENT, manufactured by Pharmaceutical Associates, Inc., is $0.6928 per ML (NDC 00121077001), effective Aug 19, 2026.

How has the price of LORAZEPAM 2 MG/ML ORAL CONCENT changed over time?

Over the history we have for it, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has risen 2.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG/ML ORAL CONCENT?

Since Nov 28, 2013, the NADAC for LORAZEPAM 2 MG/ML ORAL CONCENT has ranged from a low of $0.5070 (May 23, 2018) to a high of $0.8544 (Mar 12, 2014), with a median of $0.6251 per ML.

Are there cheaper alternatives to LORAZEPAM 2 MG/ML ORAL CONCENT?

No other NADAC-published product currently shares the active ingredient and strength of LORAZEPAM 2 MG/ML ORAL CONCENT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LORAZEPAM 2 MG/ML ORAL CONCENT?

LORAZEPAM 2 MG/ML ORAL CONCENT (NDC 00121077001) is labeled by Pharmaceutical Associates, Inc., and CMS classifies it as a generic product.